Abstract
Macrolide antimicrobials have stimulated worldwide interest owing to their therapeutic effects in various inflammatory, apparently non infectious, diseases. Abundant data are now available on their interactions with host cell (specially phagocyte) functions. Modulation of oxidant production by neutrophils and of pro-inflammatory cytokine synthesis and release by leukocytes are the two main effects observed in vitro. However, despite an extensive literature, many questions remain, such as the cellular / microbial target(s) of macrolide action, the critical chemical structure(s), and the usefulness of combining antimicrobial and anti-inflammatory properties, which during long-term treatment, could lead to increased microbial resistance. Also, because of the multiplicity of macrolide effects on different cell subsets, a unifying hypothesis for macrolide interactions with host cells is lacking. Novel analytical methods will certainly lead to new macrolide-based therapeutic strategies in cancer and inflammation.
Keywords: macrolides, ketolides, leukocytes, phagocytes, polymorphonuclear neutrophils, inflammation, immunomodulation
Current Pharmaceutical Design
Title: Cellular and Molecular Effects of Macrolides on Leukocyte Function
Volume: 10 Issue: 25
Author(s): Marie-Therese Labro
Affiliation:
Keywords: macrolides, ketolides, leukocytes, phagocytes, polymorphonuclear neutrophils, inflammation, immunomodulation
Abstract: Macrolide antimicrobials have stimulated worldwide interest owing to their therapeutic effects in various inflammatory, apparently non infectious, diseases. Abundant data are now available on their interactions with host cell (specially phagocyte) functions. Modulation of oxidant production by neutrophils and of pro-inflammatory cytokine synthesis and release by leukocytes are the two main effects observed in vitro. However, despite an extensive literature, many questions remain, such as the cellular / microbial target(s) of macrolide action, the critical chemical structure(s), and the usefulness of combining antimicrobial and anti-inflammatory properties, which during long-term treatment, could lead to increased microbial resistance. Also, because of the multiplicity of macrolide effects on different cell subsets, a unifying hypothesis for macrolide interactions with host cells is lacking. Novel analytical methods will certainly lead to new macrolide-based therapeutic strategies in cancer and inflammation.
Export Options
About this article
Cite this article as:
Labro Marie-Therese, Cellular and Molecular Effects of Macrolides on Leukocyte Function, Current Pharmaceutical Design 2004; 10 (25) . https://dx.doi.org/10.2174/1381612043383403
DOI https://dx.doi.org/10.2174/1381612043383403 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metabolic Acidosis in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review on Corrosion Protection of Iron and Steel
Recent Patents on Corrosion Science Measurement of Cerebral Blood Flow with Near Infrared Spectroscopy and Indocyanine Green Dye Dilution
Current Medical Imaging Editorial (Thematic Issue: Therapeutic Potential of microRNAs in Vascular Disease)
Current Vascular Pharmacology Meet Our Editor:
Current Cardiology Reviews Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets Immune-Mediated Mechanisms in Atherosclerosis: Prevention and Treatment of Clinical Manifestations
Current Pharmaceutical Design Genetic and Molecular Determinants of Atherosclerotic Plaque Instability
Current Vascular Pharmacology Hypoperfusion of the Aortic Wall Secondary to Degeneration of Adventitial Vasa Vasorum Causes Abdominal Aortic Aneurysms
Current Drug Targets Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study
Current Vascular Pharmacology New Devices for Treating Acute Ischemic Stroke
Recent Patents on CNS Drug Discovery (Discontinued) Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy Adrenergic and V1-ergic Agonists/Antagonists Affecting Recovery from Brain Trauma in the Lund Project Act on Astrocytes
Current Signal Transduction Therapy Patent Selections
Recent Patents on Cardiovascular Drug Discovery Intraoperative Magnetic Resonance Imaging
Current Medical Imaging Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Current Neuropharmacology The Posterior Perforated Substance: A Brain Mystery Wrapped in an Enigma
Current Topics in Medicinal Chemistry Meet Our Co-Editor
Cardiovascular & Hematological Agents in Medicinal Chemistry Pathology and Development - Developmental Systems for Target Validation and Drug Screening in Osteoarthritis
Drug Design Reviews - Online (Discontinued) Dissections of the Thoracic Aorta and Evolving Endovascular Strategies
Current Hypertension Reviews